By
MikeH on
June 21, 2012
One of the 64-million-dollar questions in the diabetes world is why more of us don’t do a better job tracking our blood sugars.
I know that’s been a key question in my 28 years of living with type 1.
Fitting with the behavioral change theme of this year’s ADA Scientific Sessions, and how doctors can motivate us to “do better,” a breakfast session explored the issue of BG logging and why it’s such a challenge…
Read more »
This is a good news + good news + bad news scenario, Folks. From announcements made at the ADA Conference in Philly, we’ve learned that long-term insulin use is shown to be safe – even Lantus use does not cause cancer risk! – but on the whole, type 1 diabetics in America aren’t faring so well, health-wise.
A huge and unprecedented study by the name of ORIGIN (Outcome Reduction with Initial Glargine Intervention) is the…
Read more »
Although many attendees were heard grumbling that “nothing groundbreaking” came out of the annual ADA Conference this weekend, I spent most of my time there darting around the Expo for one-on-one meetings with company execs, and came home with a notebook full of juicy updates on what all the “players” are up to.
(Don’t miss the Dexcom and Insulet updates! Spoiler alert: new & improved versions are being actively evaluated by FDA now)
Starting with…
Read more »